ATM Antikörper (AA 2050-2717)
Kurzübersicht für ATM Antikörper (AA 2050-2717) (ABIN1732026)
Target
Alle ATM Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 2050-2717
-
Spezifität
- Reacts with human and mouse ATM.
-
Aufreinigung
- Purified
-
Immunogen
- Synthetic peptide representing a portion of the ATM encoded within exon 53 (aa 2050-2717)
-
-
-
-
Applikationshinweise
-
Working dilution: Optimal dilution should be determined by the end user.
The following are guidelines only:
WB(0.1 - 0.4 μg/mL) IP(10 - 20 μg/mg) -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Tris citrate/phosphate, pH 7-8
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C
-
Informationen zur Lagerung
- Store at 2 - 8°C. Antibody is stable at 2 - 8°C for 1 year.
-
-
- ATM (Ataxia Telangiectasia Mutated (ATM))
-
Andere Bezeichnung
- ATM
-
Hintergrund
- Serine-protein kinase ATM Ataxia telangiectasia mutated, A-T mutated Gene name: ATM, AT1, ATA, ATC, ATD, ATE, ATDC, TEL1, TELO1
-
Gen-ID
- 472
-
UniProt
- Q13315
-
Pathways
- p53 Signalweg, Apoptose, DNA Reparatur, Inositol Metabolic Process, Positive Regulation of Response to DNA Damage Stimulus
Target
-